Skip to Content
Merck
CN

13-1890

Hydrofluoric acid

55%, CP

Synonym(s):

HF

Sign In to View Organizational & Contract Pricing.

Select a Size

About This Item

Empirical Formula (Hill Notation):
HF
CAS Number:
7664-39-3
Molecular Weight:
20.01
UNSPSC Code:
12352106
PubChem Substance ID:
329750092
MDL number:
MFCD00011346

Key Documents

View All Documentation
Technical Service
Need help? Our team of experienced scientists is here for you.
Let Us Assist
Technical Service
Need help? Our team of experienced scientists is here for you.
Let Us Assist

Product Name

Hydrofluoric acid, 55%, CP

InChI

1S/FH/h1H

SMILES string

[H+].[F-]

InChI key

KRHYYFGTRYWZRS-UHFFFAOYSA-N

grade

CP

vapor density

1.27 (vs air)

vapor pressure

25 mmHg ( 20 °C)

form

liquid

availability

available only in Japan

concentration

55%

density

1.15 g/mL at 25 °C (lit.)

Looking for similar products? Visit Product Comparison Guide

pictograms

Skull and crossbonesCorrosion
GHS06,GHS05

signalword

Danger

Hazard Classifications

Acute Tox. 1 Dermal - Acute Tox. 2 Inhalation - Acute Tox. 2 Oral - Eye Dam. 1 - Skin Corr. 1A

Storage Class

6.1B - Non-combustible acute toxic Cat. 1 and 2 / very toxic hazardous materials

wgk

WGK 2

flash_point_f

Not applicable

flash_point_c

Not applicable

Regulatory Information

新产品
This item has

Choose from one of the most recent versions:

Certificates of Analysis (COA)

Lot/Batch Number
A1572
A2548
A8468
A2436
L6370

Don't see the Right Version?

If you require a particular version, you can look up a specific certificate by the Lot or Batch number.

Search for a COA

Already Own This Product?

Find documentation for the products that you have recently purchased in the Document Library.

Visit the Document Library

Ian Ford et al.
International journal of cardiology, 184, 163-169 (2015-02-24)
We identified easily obtained baseline characteristics associated with outcomes in patients with chronic heart failure (HF) and elevated heart rate (HR) receiving contemporary guideline-recommended therapy in the SHIFT trial, and used them to develop a prognostic model. We selected the
Wenlin Yvonne Lin et al.
Waste management (New York, N.Y.), 41, 75-84 (2015-04-22)
Accelerated carbonation has been studied as a treatment method for MSW IBA, and the main advantage is that it can shorten the treatment duration from months to days, compared to natural weathering. This study investigated the effect of accelerated carbonation
Yvonne C J Wientjes et al.
Genetics, selection, evolution : GSE, 47, 42-42 (2015-05-09)
Although simulation studies show that combining multiple breeds in one reference population increases accuracy of genomic prediction, this is not always confirmed in empirical studies. This discrepancy might be due to the assumptions on quantitative trait loci (QTL) properties applied
Faiez Zannad et al.
European journal of heart failure, 17(7), 735-742 (2015-04-29)
Thrombin is a critical element of crosstalk between pathways contributing to worsening of established heart failure (HF). The aim of this study is to explore the efficacy and safety of rivaroxaban 2.5 mg bid compared with placebo (with standard care) after
Barry Greenberg et al.
JACC. Heart failure, 2(1), 84-92 (2014-03-14)
Impaired cardiac isoform of sarco(endo)plasmic reticulum Ca(2+) ATPase (SERCA2a) activity is a key abnormality in heart failure patients with reduced ejection fraction. The CUPID 2 (Calcium Up-Regulation by Percutaneous Administration of Gene Therapy in Cardiac Disease Phase 2b) trial is
View All Related Papers

Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.

Contact Technical Service